Open original FDA record ↗Recall record
- FDA identifier
- Z-1388-2018
- Company in FDA record
- Life Technologies Corporation
- FDA record creation date
- Apr 17, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Three lots of Human Fetal Hemoglobin FITC Conjugate are displaying high background and unusual bright staining in the controls and patient samples which could potentially lead to erroneous results (i.e. false positives)
Source facts
- Action
- All consignees which have purchased the Human Fetal Hemoglobin FITC antibody including facilities/customers that have shipped the lots outside of their facility will be notified via certified mail to check inventory to see if affected product is on hand. Consignees instructed to discontinue use and discard per internal procedure. The effectiveness check will begin 10 days after the distribution date of the Medical Device Recall Notification. The field removal is considered effective when 10% of the affected customers acknowledge receipt and understanding of the notification instructions.
- Initiated
- 2018-02-07
- Root cause
- Use error
- Terminated
- 2019-05-08
- Distribution
- MI, CA, IL, TX, SC, NY, MN, DE, NJ, WA , OR, IN, MA, DE, FL, PA
- Recall number
- Z-1388-2018
- Recall status
- Terminated
- CDRH record ID
- 162776
- FDA record created
- 2018-04-17
- Recall event number
- 79603